Catheter Precision, Inc. (VTAK) Total liabilities 2017–2025
Catheter Precision, Inc. (VTAK) total liabilities at each fiscal year-end, per SEC filings.
$9.2MFY2025 · since FY2017: $18.9M → $9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.2M | -42.5% |
| FY2024 | $16.0M | +67.8% |
| FY2023 | $9.5M | +26.0% |
| FY2022 | $7.6M | +2.8% |
| FY2021 | $7.4M | -40.0% |
| FY2020 | $12.3M | +12.4% |
| FY2019 | $10.9M | +49.1% |
| FY2018 | $7.3M | -61.2% |
| FY2017 | $18.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VTAK financial trends
VTAK RevenueVTAK Net incomeVTAK Net marginVTAK Gross profitVTAK Gross marginVTAK Operating incomeVTAK Operating marginVTAK Operating cash flowVTAK Free cash flowVTAK Capital expendituresVTAK Return on equityVTAK Stock buybacksVTAK Dividends paidVTAK Total assetsVTAK Shareholders’ equityVTAK overview →